Last reviewed · How we verify

NCT04135586: NEOLIFE

Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer

Recruiting now NA Last updated 27 June 2024
What this trial tests

NA trial testing Exercise training in Physical Exercise in 80 participants. Currently enrolling.

Timeline
1 January 2020
Primary endpoint
1 November 2026
1 December 2026

Quick facts

Lead sponsorUniversidad Europea de Madrid
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment80
Start date1 January 2020
Primary completion1 November 2026
Estimated completion1 December 2026
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Europea de Madrid

Who can join

Adults 25 to 75, female only, with Physical Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess in women with triple-negative breast cancer receiving neo-adjuvant chemotherapy the effects of an intense physical exercise program (intervention group) on physical capacity, compared with a control group not meeting the minimum exercise recommendations of the World Health Organization (WHO).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise training

Trials testing the same drug.

Other recruiting trials for Physical Exercise

Currently open trials in the same condition.

Other Universidad Europea de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04135586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing